If you've recently been diagnosed with breast cancer, you'll be faced with some decisions about the care you'll receive. Depending on the type, location, stage and other aspects of your cancer, you ...

Deciding how to treat your breast cancer can be a very difficult and personal decision. Dr. Cindy Matsen, breast surgeon at Huntsman Cancer Institute, says it’s easy for women who begin initial ...

Many women who are diagnosed with breast cancer face the difficult decision of whether to have a lumpectomy with radiation or a mastectomy with reconstruction. With the availability of study results ...

“You know that phrase, ‘third time’s the charm?’ ” Marilene Nevins asks. Well, not always. In 1997, a suspicious mass was found in Nevins’ right breast. “I nicknamed that one Mickey,” she says. “You ...

Dr. Silverstein answers: 'What If More Cancer is Found During Lumpectomy?' — -- Question: What will the surgeon do if more cancer is evident during lumpectomy surgery? Answer: If more cancer is ...

A lumpectomy is a surgical procedure that removes cancer from the breast. Unlike a mastectomy — which removes the entire breast — a lumpectomy removes just the area of the breast where there is cancer ...

A new U.S. study examining survival rates for women with early stage breast cancer found that surgery such as lumpectomy that preserves the rest of the breast may offer survival odds as good as, or ...

(02-06) 10:47 PST SAN FRANCISCO-- For decades, clinical trials and other studies have shown that women with early-stage breast cancer have the same survival odds whether they choose to have a surgery ...

A 31-year-old woman underwent a right lumpectomy and sentinel lymph node sampling for a breast mass. Pathology showed a 21 x 11 mm medullary carcinoma of the breast, with clear margins; lymph nodes ...

THEN TO. IT’S IMPORTANT FOR US AS A WOMAN TO FEEL COMFORTABLE WITHIN HERSELF. WHEN ARVIN RAWLINGS WAS DIAGNOSED WITH BREAST CANCER AND FOUND OUT SHE NEEDED SURGERY, SHE WORRIED HOW IT WOULD MAKE HER ...

Molecular and genomic predictors of response to single-agent doxorubicin (ADR) versus single-agent docetaxel (DOC) in primary breast cancer (PBC). Background: In women 70 years of age or older with ...